Increasing evidence combined with existing knowledge of the role APOBEC plays in mutagenesis in multiple cancer types strongly suggests APOBEC3A as a mediator of tumor response to therapy across multiple tumor types. This evidence concerns the gene APOBEC3A and cancer.